Discovery of a novel MDM2-tubulin signaling pathway as a therapeutic target in AML

$5.54M USD

Funder	NATIONAL CANCER INSTITUTE
Recipient Organization	Emory University
Country	United States
Start Date	Dec 01, 2023
End Date	Nov 30, 2028
Duration	1,826 days
Number of Grantees	2
Roles	Co-Investigator; Principal Investigator
Data Source	NIH (US)
Grant ID	`10797517`

Project Summary/Abstract Acute myeloid leukemia (AML) continues to have a dismal 5-year survival rate of

Emory University

Complete our application form to express your interest and we'll guide you through the process.

Start Year 2023

End Year 2028

Grantees 2